Scarica l'app Stockscreener
3.90
2.74%
-0.11
Dopo l'orario di chiusura:
3.90
Novabridge Biosciences Adr Borsa (NBP) Ultime notizie
NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Nigeria
NovaBridge subsidiary Visara appoints two key ophthalmology leaders - Investing.com India
NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward - GlobeNewswire Inc.
How does Talphera Inc (TLPH) change from a tortoise to a hare? - Setenews
This trade activity should not be overlooked: Zooz Strategy Ltd (ZOOZ) - setenews.com
There is no way NovaBridge Biosciences. ADR (NBP) can keep these numbers up - setenews.com
Prepare Yourself for Liftoff: Sandisk Corp (SNDK) - Setenews
NBP Financial Statements & ChartsNovabridge Biosciences.Adr MacroTrends - CMLviz
NBP Interactive Stock ChartNovabridge Biosciences.Adr. Stock Analysis - CMLviz
NBP Pivot Points, Technical Analysis and Moving AveragesNovabridge Biosciences.Adr Technicals - CMLviz
Total equity of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
Equity in earnings of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView
symbol__ Stock Quote Price and Forecast - CNN
NBP Forecast — Price Target — Prediction for 2026 - TradingView
NBP Stock Price and Chart — NASDAQ:NBP - TradingView
NBPNovaBridge Biosciences. ADR Stock Price and Quote - Finviz
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - Barchart.com
I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com
I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval - TipRanks
I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO By Investing.com - Investing.com South Africa
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga
This Bank of New York Mellon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAcadian Asset Management (NYSE:AAMI), C3.ai (NYSE:AI) - Benzinga
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga
Kimball Electronics Posts Better-Than-Expected Earnings, Joins Terawulf, Dlocal, Equinox Gold And Other Big Stocks Moving Higher On Thursday - Benzinga
Morningstar’s Best- and Worst-Performing Stocks: 2022 - Morningstar
10 of the Cheapest Stocks of 2022 - Morningstar
The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar
New 5-Star Stocks - Morningstar
ORIC Stock Price | Oric Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
ADPT Stock Price | Adaptive Biotechnologies Corp. Stock Quote (U.S.: Nasdaq) - MarketWatch
0.53%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):